Medicare Part B Reimbursement of Prescription Drugs . Introduction


Certain health care providers, especially oncologists and anesthesiologists, purchase drugs that they administer to patients as a component of their practices. These drugs include sterile injectable drugs and some drugs used in conjunction with certain durable medical equipment, such as nebulizers. Unlike the many other medical supplies that providers routinely buy in the private market, insurers often separately reimburse providers for the cost of these drugs, rather than expecting providers to cover these costs as part of their global reimbursement. The prices of the drugs themselves, however, are not subject to price regulation under Medicare, and the prices paid by providers to suppliers for these products do not depend on the type of insurance a patient has.

View full report


"ib_mprpd.pdf" (pdf, 216.76Kb)

Note: Documents in PDF format require the Adobe Acrobat Reader®. If you experience problems with PDF documents, please download the latest version of the Reader®